This company has been marked as potentially delisted and may not be actively trading. Hudson Executive Investment (HEC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HEC vs. INNV, DCGO, EUDA, PIII, KDLY, VSEE, ATPC, BTTX, UPHL, and WGSShould you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include InnovAge (INNV), DocGo (DCGO), EUDA Health (EUDA), P3 Health Partners (PIII), Kindly MD (KDLY), Vsee Health (VSEE), Agape ATP (ATPC), Better Therapeutics (BTTX), UpHealth (UPHL), and GeneDx (WGS). Hudson Executive Investment vs. InnovAge DocGo EUDA Health P3 Health Partners Kindly MD Vsee Health Agape ATP Better Therapeutics UpHealth GeneDx Hudson Executive Investment (NASDAQ:HEC) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Does the media refer more to HEC or INNV? In the previous week, Hudson Executive Investment's average media sentiment score of 0.00 equaled InnovAge'saverage media sentiment score. Company Overall Sentiment Hudson Executive Investment Neutral InnovAge Neutral Which has higher earnings and valuation, HEC or INNV? InnovAge has higher revenue and earnings than Hudson Executive Investment. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHudson Executive InvestmentN/AN/A-$27.24MN/AN/AInnovAge$806.61M0.50-$21.34M-$0.19-15.58 Is HEC or INNV more profitable? Hudson Executive Investment has a net margin of 0.00% compared to InnovAge's net margin of -3.19%. InnovAge's return on equity of -9.45% beat Hudson Executive Investment's return on equity.Company Net Margins Return on Equity Return on Assets Hudson Executive InvestmentN/A -337.48% -4.06% InnovAge -3.19%-9.45%-4.84% Do analysts rate HEC or INNV? InnovAge has a consensus target price of $5.00, suggesting a potential upside of 68.92%. Given InnovAge's stronger consensus rating and higher probable upside, analysts plainly believe InnovAge is more favorable than Hudson Executive Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hudson Executive Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Does the MarketBeat Community believe in HEC or INNV? Hudson Executive Investment and InnovAge both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformHudson Executive InvestmentN/AN/AInnovAgeOutperform VotesNo VotesUnderperform Votes5100.00% Do insiders and institutionals hold more shares of HEC or INNV? 73.4% of Hudson Executive Investment shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 1.4% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryInnovAge beats Hudson Executive Investment on 6 of the 9 factors compared between the two stocks. Remove Ads Get Hudson Executive Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HEC vs. The Competition Export to ExcelMetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$115.51M$854.00M$5.58B$7.92BDividend YieldN/A2.49%5.35%4.04%P/E RatioN/A49.9523.1218.81Price / SalesN/A3.46369.2688.71Price / CashN/A26.1438.1634.64Price / Book23.252.676.704.18Net Income-$27.24M-$5.50M$3.20B$247.10M Hudson Executive Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HECHudson Executive InvestmentN/A$2.79+4.9%N/A-23.1%$115.51MN/A0.00N/AINNVInnovAge1.5495 of 5 stars$3.12-1.3%$5.00+60.3%-36.2%$427.37M$806.61M-16.422,000Gap DownHigh Trading VolumeDCGODocGo3.0606 of 5 stars$2.77+3.7%$4.89+76.6%-29.4%$282.49M$616.56M9.892,920Short Interest ↓News CoverageGap DownEUDAEUDA HealthN/A$3.93-3.2%N/A+102.2%$96.79M$3.81M0.002PIIIP3 Health Partners1.8941 of 5 stars$0.19+8.4%$0.25+34.1%-76.8%$66.88M$1.48B-0.22500Earnings ReportShort Interest ↑KDLYKindly MD0.6886 of 5 stars$2.18+44.4%N/AN/A$13.03M$2.88M0.00N/AEarnings ReportNews CoverageGap UpHigh Trading VolumeVSEEVsee Health1.4185 of 5 stars$1.20-0.8%$5.00+316.7%N/A$4.33M$6.38M0.00N/ANews CoverageGap DownATPCAgape ATP0.5098 of 5 stars$1.06+1.0%N/A-79.8%$4.23M$1.35M-1.4540Earnings ReportUpcoming EarningsShort Interest ↓BTTXBetter TherapeuticsN/A$0.00+100.0%N/A-97.1%$20,000.00N/A0.0040Gap UpUPHLUpHealthN/A$0.00flatN/A-100.0%$4,000.00$130M0.001,750WGSGeneDx2.3162 of 5 stars$103.19-1.1%$72.33-29.9%+809.6%$2.90B$305.45M-52.651,200Gap Down Remove Ads Related Companies and Tools Related Companies InnovAge Alternatives DocGo Alternatives EUDA Health Alternatives P3 Health Partners Alternatives Kindly MD Alternatives Vsee Health Alternatives Agape ATP Alternatives Better Therapeutics Alternatives UpHealth Alternatives GeneDx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HEC) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hudson Executive Investment Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hudson Executive Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
